Biomira

The company's clinical-stage biopharmaceutical services include the development of cancer vaccines designed to stimulate the immune system to attack cancer cells, while its small-molecule compounds aim to inhibit the activity of specific cancer-related proteins, enabling doctors to quickly cure their patients.